Toft Group Executive Search has placed Mr. Carmine Stengone as Chief Executive Officer with Pipeline Therapeutics in San Diego, California. Mr. Stengone recently served as President and CEO of Avelas Biosciences. Prior to that he was Senior Vice President, Business Development for COI Pharmaceuticals. Mr. Stengone was also Vice President of Corporate Development for Afraxis Holdings, Senior Director of BD with Phenomix Corporation, and has held positions with Anadys Pharmaceuticals and Johnson & Johnson Pharmaceutical Research and Development.
Mr. Stengone holds an MBA from the Johnson Graduate School of Management at Cornell University, an M.S. in Organic Chemistry from Duke University, and a B.S. in Chemistry from Wake Forest University.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles. Toft Group has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
About Pipeline Therapeutics
Pipeline Therapeutics is using innovative research strategies to develop novel drugs for the treatment of MS and other demyelinated diseases by enhancing the functional restoration of the affected nerves.